Elderly Patients with Myelodysplastic Syndromes can Have Successful Transplants
source: pixabay.com

Elderly Patients with Myelodysplastic Syndromes can Have Successful Transplants

By Rachel Whetstone from In The Cloud Copy Many patients with myelodysplastic syndromes (MDS) are elderly when they’re diagnosed with the disease. Although stem cell transplants are often thought to…

Continue Reading Elderly Patients with Myelodysplastic Syndromes can Have Successful Transplants
Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
source: pixabay.com

Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?

According to a story from Newsfile, the biotechnology company PharmaCyte is beginning to turn heads with the potential of its proprietary Cell-in-a-Box technology that has the potential to greatly improve…

Continue Reading Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
source: pixabay.com

ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment

According to a story from gurufocus.com, the biopharmaceutical company ADMA Biologics, Inc., has earned the 2020 BioNJ Innovator Award. This award was given as acknowledgement of the company's successful development…

Continue Reading ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
Interim Gene Therapy Trial Data for Two Different Forms of Sanfilippo Syndrome Holds Promise
source: pixabay.com

Interim Gene Therapy Trial Data for Two Different Forms of Sanfilippo Syndrome Holds Promise

According to a story from gurufocus.com, the biopharmaceutical company Abeona Therapeutics, Inc., recently announced the presentation of positive interim findings from two different phase 1/2 clinical trials. These trials were…

Continue Reading Interim Gene Therapy Trial Data for Two Different Forms of Sanfilippo Syndrome Holds Promise
Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
source: pixabay.com

Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“

  The ASCO Post recently reported findings of high response rates and improved survival from the combination of platinum-based cisplatin and gemcitabine (chemotherapy) in BRCA/PALB2 mutation positive pancreatic ductal adenocarcinoma. The goal…

Continue Reading Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
Close Menu